Posts by David Brownstein

Tackling Clinical Trial Accruals: A Guide for Med Tech Finance Leaders
As clinical activity ramps up, so does scrutiny—from auditors, boards, and investors. For finance leaders of life sciences and medical device companies, few areas generate more complexity than accruing for clinical trial costs at period end. Invoices often lag the actual work performed, Clinical Research Organization (“CRO”) reporting can be inconsistent, and patient activity varies Read more...

10 Years Later: 10 Reasons Why I Still Love Working at Haskell & White
This May (May 29, 2022, to be exact) will mark my ten-year anniversary at Haskell & White, a Southern California CPA firm. With all the publicity surrounding “The Great Resignation”, and particularly its impact on the public accounting industry, I’d like to share my top – 10 reasons why I still love working here – Read more...

Going Concern Disclosures Today
With the COVID-19 pandemic well into its second year and the start of planning for the upcoming audit season, you may have questions about how to evaluate your company’s going concern status. While some industries appear to have rebounded from the worst of the economic downturn, others continue to struggle with pandemic-related issues, such as Read more...